Polyethylene glycol for constipation: how it works, how to take it, and risks

Polyethylene glycol is an osmotic laxative. It retains water in the intestinal lumen, resulting in softer stools and typically increased bowel movements. This is how it is described in MedlinePlus and the official US labeling for polyethylene glycol 3350. [1]

In everyday practice, it's important to understand that the word "polyethylene glycol" refers to different dosage forms. There's regular polyethylene glycol 3350 powder for treating constipation, and there are polyethylene glycol solutions with electrolytes for bowel preparation before colonoscopy. These are not the same in terms of purpose or dosage regimens. [2]

In British sources, the same class of drugs is often referred to as macrogol. The British National Health Service states that macrogol is used to treat constipation and to relieve faecal impaction, the accumulation of hard stool in the intestines. This helps avoid confusion between brand names and helps clarify that these are essentially similar osmotic laxatives. [3]

The effect is not immediate. According to official instructions and MedlinePlus, bowel movements typically occur within 1-4 days, while the British National Health Service more often recommends an interval of 1-2 days. Therefore, polyethylene glycol is better suited for a gentle, predictable osmotic effect than for an urgent "quick cleanse" in a few hours. [4]

Polyethylene glycol alone does not address the underlying cause of constipation. Even with a good response to the drug, MedlinePlus and the National Institute of Diabetes and Digestive and Kidney Diseases recommend maintaining adequate fluid intake, fiber, and physical activity, as without these, long-term symptom control is often poorer. [5]

Parameter	What is important to know
Pharmacological group	Osmotic laxative
The main mechanism	Retains water in stool
Main result	Softens stool and facilitates bowel movements
Typical validity period	Usually 1-4 days
Main area of application	Episodic and chronic constipation, sometimes fecal impaction
What it doesn't do	Does not treat the cause of constipation on its own

The table summarizes the basic properties of the drug according to official instructions and medical reference sources. [6]

What is the place of polyethylene glycol in modern recommendations?

In modern gastroenterology, polyethylene glycol occupies a very strong position in the treatment of chronic idiopathic constipation in adults. The 2023 joint guideline of the American Gastroenterological Association and the American College of Gastroenterology not only allows its use, but recommends its use over no polyethylene glycol. Compared to other over-the-counter medications, this is one of the strongest messages in the guideline. [7]

This is especially important given the overall spectrum of treatment options. The same guideline recommends dietary fiber first, then polyethylene glycol, and only then magnesium, lactulose, bisacodyl, sodium picosulfate, senna, and prescription medications for those who have not responded to over-the-counter therapy. This order demonstrates that polyethylene glycol has long ceased to be a "simple backup laxative" and has become one of the standard starting options. [8]

The drug's position in pediatrics is also very strong. A 2025 review of current treatments for functional constipation in children indicates that polyethylene glycol and lactulose remain the most commonly used first-line osmotic laxatives in clinical practice. Another review and research publications from 2025 explicitly cite polyethylene glycol as the first choice for the relief of fecal impaction in children. [9]

The reason for this is fairly clear. Polyethylene glycol works predictably, is generally well tolerated, and is suitable for both short-term symptomatic use and longer-term regimens under medical supervision. The British National Health Service states that the drug is typically used for up to two weeks, but in cases of severe constipation or constipation caused by medications, a doctor may recommend it for many months. [10]

However, polyethylene glycol has not supplanted all other options. If there is no response, the effect is insufficient, or there is intolerance, current guidelines allow for switching to other osmotic, stimulating, and prescription medications. This is important because even a strong recommendation does not mean a drug is equally ideal for every patient. [11]

Clinical situation	The role of polyethylene glycol
Chronic idiopathic constipation in adults	One of the main recommended options
Episodic constipation	Often appropriate as an over-the-counter remedy
Functional constipation in children	One of the first-line drugs
Fecal impaction in children	Often considered as the first choice
Lack of response to food measures	Often the logical next step
Ineffectiveness of polyethylene glycol	Transition to other schemes and further examination

The table reflects the place of the drug in modern adult and pediatric algorithms. [12]

When the drug is especially useful and how it is usually taken

Polyethylene glycol is particularly useful where a gentle osmotic effect without severe bowel stimulation is needed. This makes it suitable for occasional constipation, chronic idiopathic constipation, and a number of fecal impaction treatment regimens. In British practice, it is also used for the long-term management of patients with persistent constipation, if recommended by a physician. [13]

For regular over-the-counter polyethyleneglycol 3350 in the US, the standard adult dose is 17 g once daily, dissolved in 120-240 ml of beverage, for no longer than 7 days without consulting a doctor. This is clearly stated in the official DailyMed instructions. MedlinePlus also recommends once daily dosing as needed, usually for up to 2 weeks. The difference in duration reflects the difference between over-the-counter instructions and clinical use under a doctor's supervision. [14]

The UK National Health Service (NHS) provides a wider dosage range for macrogol electrolyte sachets. For adults and children 12 years and older, the typical dosage for constipation is 1 full-strength sachet 1-3 times daily. For faecal impaction, the recommended dosage range is 4 sachets on day 1, gradually increasing to 8 sachets daily. This demonstrates the importance of not automatically transferring dosages from one form to another. [15]

For children, regimens vary even more depending on age and the specific dosage form. The UK's National Health Service lists separate dosages for children under 12 years of age and emphasizes that children's sachets should be prescribed by a doctor. Recent reviews from 2025 also remind that therapy in children should be individualized, as the severity of constipation, the presence of faecal impaction, and the response to treatment vary greatly. [16]

In practice, the drug is usually taken not "by the hour to speed up the effect," but regularly at the recommended dose until stools become soft and predictable. The British National Health Service emphasizes that with long-term treatment, the dose can often be reduced to 1-2 sachets per day. This well illustrates the general principle of titration: no more than is needed for a stable result. [17]

Scenario	Typical scheme according to official sources
Adults, regular polyethylene glycol 3350	17 g once a day
Adults, Macrogol in sachets for constipation	1 sachet 1-3 times a day
Adults, fecal impaction	From 4 sachets per day increasing to 8
Children under 12 years of age	Only according to the doctor's prescription and age-appropriate form
Usual duration without a doctor	Usually up to 7-14 days
Long-term therapy under the supervision of a physician	Possible within months

The table combines data from US official guidelines, MedlinePlus and UK dosing schedules.[18]

Side effects, contraindications and important precautions

Although polyethylene glycol is generally well-tolerated, it does have side effects. MedlinePlus lists nausea, bloating, cramping, and gas, while the UK's National Health Service adds diarrhea, vomiting, and anal irritation. In most cases, these symptoms subside with a reduction in dosage or after stools become softer and more regular. [19]

The main concern with overdose or an overly aggressive regimen is severe diarrhea. The UK's National Health Service warns that severe diarrhea or vomiting can lead to changes in blood electrolytes. Rare, serious symptoms include severe weakness, shortness of breath, swelling of the legs, muscle weakness, and irregular heart rhythm. These are rare but clinically important complications, especially in fragile patients. [20]

Contraindications and warnings often vary depending on the form of the medication. For over-the-counter polyethylene glycol 3350, DailyMed recommends not using the medication if you have kidney disease without consulting a doctor. Also, consult a doctor if you experience nausea, vomiting, abdominal pain, irritable bowel syndrome, or a sudden change in bowel habits lasting longer than 2 weeks. MedlinePlus specifically recommends always reporting any intestinal obstruction and its symptoms to your doctor. [21]

The UK National Health Service lists a more extensive list of restrictions for macrogol electrolyte sachets. These include intestinal perforation, intestinal obstruction or intestinal paralysis, ulcerative colitis, Crohn's disease, toxic megacolon, the need to use liquid thickeners for swallowing problems, as well as certain cardiac conditions and dietary salt restrictions. This is especially important when taking high doses over a long period of time, as some forms contain significant amounts of sodium. [22]

A separate practical detail is not to mix the powder with starch-containing thickeners for people with swallowing difficulties. DailyMed specifically warns against this. This is a subtle but important safety issue, as it's in such situations that the specific features of a particular dosage form can be easily overlooked. [23]

Risk or limitation	What is important to remember
Bloating, gas, cramping, nausea	The most common side effects
Diarrhea	Often means the dose is too high
Severe diarrhea or vomiting	May disrupt electrolyte balance
Intestinal obstruction	Contraindication
Severe inflammatory bowel disease in the active phase	Require special care, especially for forms with electrolytes
Kidney disease for a number of over-the-counter forms	A doctor's consultation is required
Low-salt diet or heart failure	Important for forms with electrolytes

The table summarizes general and form-specific risks that should be considered before starting treatment. [24]

Special groups: children, pregnancy, breastfeeding and the elderly

Polyethylene glycol plays a very important role in children. A modern 2025 review emphasizes that in clinical practice, polyethylene glycol and lactulose remain the most commonly used first-line osmotic laxatives, and other 2025 publications specifically cite polyethylene glycol as the first choice for relieving fecal impaction in children with functional constipation. This makes the drug one of the central tools in pediatric gastroenterology. [25]

However, self-administration in children without a doctor's advice is not always appropriate. The British National Health Service (NHS) states that children under 12 years of age should only receive macrogol with a doctor's prescription, and the age-specific guidelines differ significantly from those for adults. This is especially important for infants, preschoolers, and those with suspected faecal impaction. [26]

Macrogol is considered an acceptable option during pregnancy. The UK's National Health Service specifically states that macrogol can be taken during pregnancy, although it is always recommended to first try non-drug measures such as increased fiber, fluid intake, and gentle physical activity. If this is insufficient, a doctor or midwife may recommend macrogol as a laxative. [27]

The position regarding breastfeeding is even more relaxed. The UK's National Health Service states that macrogol can be taken during breastfeeding and that it does not pass into breast milk in significant quantities. The UK's dedicated Medicines Safety in Breastfeeding Authority also considers macrogol 3350 an acceptable option. [28]

In elderly patients, the drug is often convenient precisely because it acts gently and does not require strong stimulation of motor functions. However, in this group, it is especially important to monitor hydration, dose tolerance, and electrolytes during severe diarrhea, as well as consider heart failure, arrhythmia, a low-salt diet, and drug interactions. Therefore, it is especially important for elderly patients to distinguish between simple polyethyleneglycol 3350 and forms containing electrolytes. [29]

Patient group	Practical conclusion
Children	One of the main first-line drugs, but according to the doctor's prescription
Fecal impaction in children	Often one of the first treatment options
Pregnant women	Let's say if nutrition and regimen didn't help
Nursing	Usually acceptable
Elderly	Often convenient, but requires assessment of associated risks
Patients on a low-salt diet	The form of the drug must be taken into account

The table shows that for different groups of patients the drug is not automatically prohibited, but requires different caution and choice of form. [30]

When polyethylene glycol is no longer enough and when a doctor is needed

Polyethylene glycol works well for many types of functional constipation, but it should not be used as a way to "turn a blind eye" to dangerous symptoms. DailyMed's official instructions clearly state that if rectal bleeding, increased nausea, bloating, cramping, or abdominal pain occur, or if you need to use a laxative for more than 1 week without improvement, consult a doctor. [31]

MedlinePlus also recommends always reporting possible intestinal obstruction to your doctor, and federal and clinical guidelines on constipation generally emphasize the importance of warning signs: vomiting, severe abdominal pain, sudden, prolonged changes in stool, blood in the stool, and systemic deterioration. In such situations, the cause may not be simple functional constipation. [32]

For some people, the lack of effect is not due to the "weakness" of the medication, but to another mechanism of constipation. For example, in cases of pelvic floor muscle dyssynergia, severe slow transit, drug-induced constipation, or an organic cause, osmotic therapy alone may not be sufficient. This is why current recommendations recommend moving on to the next step after failure of over-the-counter remedies—other laxatives, prescription medications, or further evaluation. [33]

In practice, this means that polyethylene glycol should not be increased indefinitely on one's own. If stable soft stools are not achieved within a reasonable period of time, the regimen requires revision. For chronic constipation, the doctor may add dietary fiber, magnesium, a stimulant laxative as rescue therapy, lactulose, or more specialized medications, and sometimes refer the patient for a pelvic floor examination. [34]

The most useful way to view polyethylene glycol is as a powerful and well-studied tool, not as a one-size-fits-all solution for constipation. The longer the symptoms last, the more warning signs, and the more complex the overall medical background, the more important it is to conduct a thorough clinical assessment rather than simply choosing the next dose. [35]

Situation	What to do
Episodic constipation without alarming symptoms	A short course according to the instructions is acceptable.
There is no effect within the expected timeframe.	Review the plan with your doctor
It needs to be taken for longer than 1-2 weeks	Discuss the reason and further plan
There was blood coming from the rectum	Seek medical attention immediately
There is vomiting, severe pain, suspicion of obstruction	Do not self-medicate
Recurrent chronic constipation	A comprehensive diagnostic and treatment algorithm is needed

The table reflects the boundary between reasonable self-care and situations where medical management is required. [36]

FAQ

Is polyethylene glycol a strong or mild laxative?
It's an osmotic laxative with a generally gentle and predictable action. It doesn't sharply stimulate the bowels, but rather retains water in the stool, making bowel movements easier. [37]

How long does it usually take for it to work?
Depending on the form and source, it's usually 1-4 days. Official instructions often say 1-3 days, MedlinePlus says 2-4 days, and the UK National Health Service often says 1-2 days. [38]

Can it be taken long-term?
For routine over-the-counter use, a short course of approximately 7-14 days is usually recommended. However, a doctor may prescribe the medication for months if constipation is severe or associated with other medications. [39]

Is it suitable for children?
Yes, and in pediatric practice, it is one of the main first-line drugs. However, treatment regimens for children are age-dependent, and for children under 12 years of age, the drug should usually be prescribed by a doctor. [40]

Is it safe to take during pregnancy and breastfeeding?
According to the UK's National Health Service, macrogol can be taken during pregnancy and breastfeeding if non-drug measures have failed. During breastfeeding, it is almost never excreted into milk. [41]

How is it better than lactulose or fiber?
It's not always "better" for everyone, but for adults with chronic idiopathic constipation, current guidelines particularly strongly support polyethylene glycol. In clinical practice, it is often chosen due to its favorable combination of efficacy, tolerability, and ease of use. [42]

Key points from experts

Lin Chang, MD, professor of medicine and vice chair of the Division of Digestive Diseases at the University of California, Los Angeles, is a co-author of a joint guideline on chronic idiopathic constipation. Her work is important to this topic because modern adult constipation treatment strategies rely not on habits but on the power of recommendations. Polyethylene glycol plays a central role in this algorithm among over-the-counter medications. [43]

William D. Chey, MD, H. Marvin Pollard Professor of Gastroenterology, Professor of Nutritional Sciences, and Chief of the Division of Gastroenterology and Hepatology at the University of Michigan, is a co-author of the same guideline. The practical significance of his approach lies in stepwise therapy: starting with effective over-the-counter options, then escalating as needed. For polyethylene glycol, this means its role as a primary, rather than a backup, tool in the modern treatment regimen. [44]

Marc Benninga, MD, Professor of Pediatric Gastroenterology at Amsterdam University Medical Center, is a researcher on pediatric functional constipation and fecal incontinence. His research is particularly important for pediatrics: polyethylene glycol remains one of the main first-line osmotic laxatives in children, and has a particularly strong position in practical algorithms for fecal impaction. [45]